Statement Of Cash Flows [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
2021-01-01 to 2021-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest income |
40,000
EUR
|
349,000
EUR
|
| Adjustments for dividend income |
-
EUR
|
-
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
1,031,000
EUR
|
2,616,000
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
4,140,000
EUR
|
1,596,000
EUR
|
| Adjustments for decrease (increase) in biological assets |
1,529,000
EUR
|
9,347,000
EUR
|
| Adjustments for amortisation expense |
16,000
EUR
|
10,000
EUR
|
| Adjustments for depreciation expense |
6,661,000
EUR
|
7,811,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
202,000
EUR
|
2,557,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
2,000
EUR
|
287,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment |
393,000
EUR
|
-
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
2,701,000
EUR
|
5,928,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
6,000,000
EUR
|
-
EUR
|